Growth Metrics

Myomo (MYO) Other Non Operating Income (2016 - 2025)

Myomo posted quarterly Other Non Operating Income of -$9743.0 for Q3 2025, down 112.82% year-on-year from $76020.0 in Q3 2024, and down 109.14% on a QoQ basis from $106549.0 in Q2 2025.

Myomo (MYO) has 10 years of Other Non Operating Income data on file, last reported at -$9743.0 in Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income fell 112.82% year-over-year to -$9743.0; the trailing twelve-month figure through Sep 2025 stood at $358828.0 (up 629.15% YoY), and the FY2024 full-year result was $388586.0, up 329.25% from the prior year.
  • Other Non Operating Income for Q3 2025 stood at -$9743.0, down from $106549.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $191991.0 in Q1 2025 and bottomed at -$269343.0 in Q4 2023.
  • The 5-year median for Other Non Operating Income is $10193.0 (2021), against an average of $25794.4.
  • The widest annual swing landed in 2023, when Other Non Operating Income plunged 33180.77%; it then jumped 886.5% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at $10193.0 in 2021, then slumped by 580.66% to -$48994.0 in 2022, then plunged by 449.75% to -$269343.0 in 2023, then surged by 126.0% to $70031.0 in 2024, then tumbled by 113.91% to -$9743.0 in 2025.
  • The last three Other Non Operating Income figures came in at -$9743.0 (Q3 2025), $106549.0 (Q2 2025), and $191991.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -9,743.00
Jun 30, 2025 106,549.00
Mar 31, 2025 191,991.00
Dec 31, 2024 70,031.00
Sep 30, 2024 76,020.00
Jun 30, 2024 107,242.00
Mar 31, 2024 135,293.00
Dec 31, 2023 -269,343.00
Sep 30, 2023 70,124.00
Jun 30, 2023 85,294.00
Mar 31, 2023 -17,202.00
Dec 31, 2022 -48,994.00
Sep 30, 2022 12,307.00
Jun 30, 2022 -19,528.00
Mar 31, 2022 52.00
Dec 31, 2021 10,193.00
Sep 30, 2021 -4,055.00
Jun 30, 2021 -6,018.00
Mar 31, 2021 -119.00
Dec 31, 2020 -364,789.00
Sep 30, 2020 -189,155.00
Jun 30, 2020 -437,302.00
Mar 31, 2020 -378,953.00
Dec 31, 2019 -180,688.00
Sep 30, 2019 36,930.00
Jun 30, 2019 141,017.00
Mar 31, 2019 84,735.00
Dec 31, 2018 43,073.00
Sep 30, 2018 58,607.00
Jun 30, 2018 52,503.00
Mar 31, 2018 57,495.00
Dec 31, 2017 -135,244.00
Sep 30, 2017 176,024.00
Jun 30, 2017 -5.45 Mn
Mar 31, 2017 -192,711.00
Dec 31, 2016 -569,739.00
Sep 30, 2016 84,439.00
Jun 30, 2016 71,311.00